Identifying innate immune pathways of the chicken may lead to new antiviral therapies

Veterinary Immunology and Immunopathology

Volumn 148, Issue 1-2, 2012, Pages 100-109

  Karpala, Adam J ^a   Lowenthal, John W ^a   Bean, Andrew G D ^a  

^a CSIRO   (Australia)

Author keywords

Antivirals; DsRNA; Interferon; RIG I like helicases; Toll like receptors

Indexed keywords

ADENOSINE DEAMINASE; AMANTADINE; ANTIBODY; BETA INTERFERON; DOUBLE STRANDED DNA; GAMMA INTERFERON; HEMAGGLUTININ; INTERFERON; PROTEIN KINASE R; RETINOIC ACID INDUCIBLE PROTEIN I; RIMANTADINE; SIALIDASE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CHICKEN; HUMAN; INFECTION CONTROL; INNATE IMMUNITY; MICROORGANISM DETECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS IMMUNITY;

ANIMALS; CHICKENS; DISEASE OUTBREAKS; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS;

AVES; MAMMALIA;

EID: 84864146894     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.05.031     Document Type: Article

References (145)

1. Aebi M., Fah J., Hurt N., Samuel C.E., Thomis D., Bazzigher L., Pavlovic J., Haller O., Staeheli P. cDNA structures and regulation of two interferon-induced human Mx proteins. Mol. Cell. Biol. 1989, 9:5062-5072.
2. Alexander D.J. An overview of the epidemiology of avian influenza. Vaccine 2006, 25:5637-5644.
3. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
4. Ampofo K., Gesteland P.H., Bender J., Mills M., Daly J., Samore M., Byington C., Pavia A.T., Srivastava R. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 2006, 118:2409-2417.
5. Asahi-Ozaki Y., Itamura S., Ichinohe T., Strong P., Tamura S.I., Takahashi H., Sawa H., Moriyama M., Tashiro M., Sata T., Kurata T., Hasegawa H. Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection. Microbes Infect. 2006, 8:2706-2714.
6. Ashkar A.A., Yao X.D., Gill N., Sajic D., Patrick A.J., Rosenthal K.L. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J. Infect. Dis. 2004, 190:1841-1849.
7. Assier E., Marin-Esteban V., Haziot A., Maggi E., Charron D., Mooney N. TLR7/8 agonists impair monocyte-derived dendritic cell differentiation and maturation. J. Leukoc. Biol. 2007, 81:221-228.
8. Balkissoon D., Staines K., McCauley J., Wood J., Young J., Kaufman J., Butter C. Low frequency of the Mx allele for viral resistance predates recent intensive selection in domestic chickens. Immunogenetics 2007, 59:687-691.
9. Bass B.L. How does RNA editing affect dsRNA-mediated gene silencing?. Cold Spring Harb. Symp. Quant. Biol. 2006, 71:285-292.
10. Bekisz J., Schmeisser H., Hernandez J., Goldman N.D., Zoon K.C. Human interferons alpha, beta and omega. Growth Factors 2004, 22:243-251.
11. Borysiewicz E., Fil D., Konat G.W. Rho proteins are negative regulators of TLR2, TLR3, and TLR4 signalling in astrocytes. J. Neurosci. Res. 2009, 87:1565-1572.
12. Bowie A.G., Haga I.R. The role of Toll-like receptors in the host response to viruses. Mol. Immunol. 2005, 42:859-867.
13. Boyle D.B., Selleck P., Heine H.G. Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin. Aust. Vet. J. 2000, 78:44-48.
14. Bright R.A., Medina M.J., Xu X., Perez-Oronoz G., Wallis T.R., Davis X.M., Povinelli L., Cox N.J., Klimov A.I. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005, 366:1175-1181.
15. Brownlie R., Zhu J., Allan B., Mutwiri G.K., Babiuk L.A., Potter A., Griebel P. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides. Mol. Immunol. 2009, 46:3163-3170.
16. Chew-Lim M., Ng C.Y. Recurrent viruses in a Singapore intensive pig farming estate. Ann. Acad. Med. Singapore 1987, 16:651-654.
17. Childs K., Stock N., Ross C., Andrejeva J., Hilton L., Skinner M., Randall R., Goodbourn S. MDA-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 2007, 359:190-200.
18. Chuang T., Ulevitch R.J. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 2001, 1518:157-161.
19. Chuang T.H., Ulevitch R.J. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 2000, 11:372-378.
20. Cox N.J., Subbarao K. Influenza. Lancet 1999, 354:1277-1282.
21. de Jong M.D., Hien T.T. Avian influenza A (H5N1). J. Clin. Virol. 2005, 35:2-13.
22. Der S.D., Lau A.S. Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:8841-8845.
23. Der S.D., Zhou A., Williams B.R., Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:15623-15628.
24. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e., Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
25. Docampo R. New and re-emerging infectious diseases. Trends Parasitol. 2002, 18:334-336.
26. Doyle S.E., Vaidya S.A., O'Connell R., Dadgostar H., Dempsey P.W., Wu T.-T., Rao G., Sun R., Haberland M.E., Modlin R.L., Cheng G. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002, 17:251-263.
27. Dumoutier L., Tounsi A., Michiels T., Sommereyns C., Kotenko S.V., Renauld J.C. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signalling. J. Biol. Chem. 2004, 279:32269-32274.
28. Elkins K.L., Rhinehart-Jones T.R., Stibitz S., Conover J.S., Klinman D.M. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 1999, 162:2291-2298.
29. Fielding R., Bich T.H., Quang L.N., Lam W.W., Leung G.M., Tien T.Q., Ho E.Y., Anht le V. Live poultry exposures, Hong Kong and Hanoi, 2006. Emerg. Infect. Dis. 2007, 13:1065-1067.
30. Garcia-Sastre A., Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006, 312:879-882.
31. Gil J., Garcia M.A., Gomez-Puertas P., Guerra S., Rullas J., Nakano H., Alcami J., Esteban M. TRAF family proteins link PKR with NF-kappa B activation. Mol. Cell. Biol. 2004, 24:4502-4512.
32. Gilli F., Marnetto F., Caldano M., Sala A., Malucchi S., Capobianco M., Bertolotto A. Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. Mult. Scler. 2006, 12:47-57.
33. Gillim-Ross L., Subbarao K. Emerging respiratory viruses: challenges and vaccine strategies. Clin. Microbiol. Rev. 2006, 19:614-636.
34. Gitlin L., Barchet W., Gilfillan S., Cella M., Beutler B., Flavell R.A., Diamond M.S., Colonna M. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:8459-8464.
35. Gonzalez-Lopez C., Martinez-Costas J., Esteban M., Benavente J. Evidence that avian reovirus sigmaA protein is an inhibitor of the double-stranded RNA-dependent protein kinase. J. Gen. Virol. 2003, 84:1629-1639.
36. Gorski K.S., Waller E.L., Bjornton-Severson J., Hanten J.A., Riter C.L., Kieper W.C., Gorden K.B., Miller J.S., Vasilakos J.P., Tomai M.A., Alkan S.S. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int. Immunol. 2006, 18:1115-1126.
37. Gowen B.B., Wong M.H., Jung K.H., Sanders A.B., Mitchell W.M., Alexopoulou L., Flavell R.A., Sidwell R.W. TLR3 is essential for the induction of protective immunity against punta toro virus infection by the double-stranded RNA (dsRNA), Poly(I:C12U), but not Poly(I:C): differential recognition of synthetic dsRNA molecules. J. Immunol. 2007, 178:5200-5208.
38. Guillot L., Le Goffic R., Bloch S., Escriou N., Akira S., Chignard M., Si-Tahar M. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 2005, 280:5571-5580.
39. Gursel M., Verthelyi D., Klinman D.M. CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells. Eur. J. Immunol. 2002, 32:2617-2622.
40. Hammerbeck D.M., Burleson G.R., Schuller C.J., Vasilakos J.P., Tomai M., Egging E., Cochran F.R., Woulfe S., Miller R.L. Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats. Antiviral Res. 2006, 73:1-11.
41. Hartwig D., Schutte C., Warnecke J., Dorn I., Hennig H., Kirchner H., Schlenke P. The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells. J. Viral Hepat. 2006, 13:150-157.
42. Hay A.J., Wolstenholme A.J., Skehel J.J., Smith M.H. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 1985, 4:3021-3024.
43. He G., Qiao J., Dong C., He C., Zhao L., Tian Y. Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China. Antiviral Res. 2007, 77:72-76.
44. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
45. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
46. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002, 3:196-200.
47. Hewson C.A., Jardine A., Edwards M.R., Laza-Stanca V., Johnston S.L. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J. Virol. 2005, 79:12273-12279.
48. Higgs R., Cormican P., Cahalane S., Allan B., Lloyd A.T., Meade K., James T., Lynn D.J., Babiuk L.A., O'farrelly C. Induction of a novel chicken Toll-like receptor following Salmonella enterica serovar Typhimurium infection. Infect. Immun. 2006, 74:1692-1698.
49. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Endres S., Hartmann G. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314:994-997.
50. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., Latz E., Fitzgerald K.A. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
51. Ichinohe T., Watanabe I., Ito S., Fujii H., Moriyama M., Tamura S., Takahashi H., Sawa H., Chiba J., Kurata T., Sata T., Hasegawa H. Synthetic double-stranded RNA Poly(I:C) combined with mucosal vaccine protects against influenza virus infection. J. Virol. 2005, 79:2910-2919.
52. Iqbal M., Philbin V.J., Smith A.L. Expression patterns of chicken Toll-like receptor mRNA in tissues, immune cell subsets and cell lines. Vet. Immunol. Immunopathol. 2005, 104:117-127.
53. Jenkins K.A., Lowenthal J.W., Kimpton W., Bean A.G. The in vitro and in vivo responses of chickens to TLR9 subfamily ligands. Dev. Comp. Immunol. 2009, 33:660-667.
54. Karpala A.J., Lowenthal J.W., Bean A.G. Activation of the TLR3 pathway regulates IFNbeta production in chickens. Dev. Comp. Immunol. 2008, 32:435-444.
55. Karpala A.J., Morris K.R., Broadway M., McWaters P., O'Neill T., Lowenthal J.W., Bean A.G. Molecular cloning, in vitro expression and characterisation of chicken interferon λ. J. Interferon Cytokine Res. 2008, 27:341-350.
56. Karpala A., Stewart C., McKay J., Lowenthal J., Bean A.G.D. Characterisation of chicken Mda5 activity: regulation of IFNβ in the absence of RIG-I functionality. J. Immunol. 2011, 186:5397-5405.
57. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Reis e., Sousa C., Matsuura Y., Fujita T., Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
58. Kawai T., Akira S. Antiviral signalling through pattern recognition receptors. J. Biochem. 2007, 141:137-145.
59. Keestra A.M., de Zoete M.R., Bouwman L.I., van Putten J.P. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9. J. Immunol. 2010, 185:460-467.
60. Kirschning C.J., Bauer S. Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses. Int. J. Med. Microbiol. 2001, 291:251-260.
61. Ko J.H., Asano A., Kon Y., Watanabe T., Agui T. Characterization of the chicken PKR: polymorphism of the gene and antiviral activity against vesicular stomatitis virus. Jpn. J. Vet. Res. 2004, 51:123-133.
62. Kochs G., Garcia-Sastre A., Martinez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J. Virol. 2007, 81:7011-7021.
63. Kobasa D., Jones S.M., Shinya K., Kash J.C., Copps J., Ebihara H., Hatta Y., Kim J.H., Halfmann P., Hatta M., Feldmann F., Alimonti J.B., Fernando L., Li Y., Katze M.G., Feldmann H., Kawaoka Y. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007, 445:319-323.
64. Kuhen K.L., Shen X., Carlisle E.R., Richardson A.L., Weier H.U., Tanaka H., Samuel C.E. Structural organization of the human gene (PKR) encoding an interferon-inducible RNA-dependent protein kinase (PKR) and differences from its mouse homolog. Genomics 1996, 36:197-201.
65. Landolfo S., Gariglio M., Gribaudo G., Garotta G. Double-stranded RNAs as gene activators. Prog. Mol. Subcell. Biol. 1994, 4:15-27.
66. Langland J.O., Jacobs B.L. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. Virology 2004, 324:419-429.
67. Le Goffic R., Balloy V., Lagranderie M., Alexopoulou L., Escriou N., Flavell R., Chignard M., Si-Tahar M. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2006, 2:e53.
68. Le Goffic R., Pothlichet J., Vitour D., Fujita T., Meurs E., Chignard M., Si-Tahar M. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 2007, 178:3368-3372.
69. Lee C.W., Senne D.A., Suarez D.L. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J. Virol. 2004, 78:8372-8381.
70. Lee C.W., Senne D.A., Suarez D.L. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (differentiating infected from vaccinated animals) strategy for the control of avian influenza. Vaccine 2004, 22:3175-3181.
71. Lee C.W., Suarez D.L. Avian influenza virus: prospects for prevention and control by vaccination. Anim. Health Res. Rev. 2005, 6:1-15.
72. Levy O., Suter E.E., Miller R.L., Wessels M.R. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood 2006, 108:1284-1290.
73. Li K.S., Guan Y., Wang J., Smith G.J., Xu K.M., Duan L., Rahardjo A.P., Puthavathana P., Buranathai C., Nguyen T.D., Estoepangestie A.T., Chaisingh A., Auewarakul P., Long H.T., Hanh N.T., Webby R.J., Poon L.L., Chen H., Shortridge K.F., Yuen K.Y., Webster R.G., Peiris J.S. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004, 430:209-213.
74. Li S., Min J.Y., Krug R.M., Sen G.C. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 2006, 349:13-21.
75. Li X.Y., Qu L.J., Yao J.F., Yang N. Skewed allele frequencies of an Mx gene mutation with potential resistance to avian influenza virus in different chicken populations. Poult. Sci. 2006, 85:1327-1329.
76. Li X.Y., Qu L.J., Hou Z.C., Yao J.F., Xu G.Y., Yang N. Genomic structure and diversity of the chicken Mx gene. Poult. Sci. 2007, 86:786-789.
77. Loo Y.M., Fornek J., Crochet N., Bajwa G., Perwitasari O., Martinez-Sobrido L., Akira S., Gill M.A., Garcia-Sastre A., Katze M.G., Gale M. Distinct RIG-I and MDA5 signalling by RNA viruses in innate immunity. J. Virol. 2007, 82:335-345.
78. Lund J., Sato A., Akira S., Medzhitov R., Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 2003, 198:513-520.
79. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams N.C., Gale N.W., Iwasaki A., Flavell R.A. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:5598-5603.
80. Luschow D., Werner O., Mettenleiter T.C., Fuchs W. Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine 2001, 19:4249-4259.
81. Majde J.A. Viral double-stranded RNA, cytokines, and the flu. J. Interferon Cytokine Res. 2000, 20:259-272.
82. Majde J.A., Brown R.K., Jones M.W., Dieffenbach C.W., Maitra N., Krueger J.M., Cady A.B., Smitka C.W., Maassab H.F. Detection of toxic viral-associated double-stranded RNA (dsRNA) in influenza-infected lung. Microb. Pathog. 1991, 10:105-115.
83. Manche L., Green S.R., Schmedt C., Mathews M.B. Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol. Cell. Biol. 1992, 12:5238-5248.
84. Marcus P.I., Sekellick M.J. Combined sequential treatment with interferon and dsRNA abrogates virus resistance to interferon action. J. Interferon Cytokine Res. 2001, 21:423-429.
85. Marschall M., Zach A., Hechtfischer A., Foerst G., Meier-Ewert H., Haller O. Inhibition of influenza C viruses by human MxA protein. Virus Res. 2000, 67:179-188.
86. Mase M., Imada T., Nakamura K., Tanimura N., Imai K., Tsukamoto K., Yamaguchi S. Experimental assessment of the pathogenicity of H5N1 influenza A viruses isolated in Japan. Avian Dis. 2005, 49:582-584.
87. Matsumoto M., Funami K., Tanabe M., Oshiumi H., Shingai M., Seto Y., Yamamoto A., Seya T. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 2003, 171:3154-3162.
88. Matsumoto M., Kikkawa S., Kohase M., Miyake K., Seya T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signalling. Biochem. Biophys. Res. Commun. 2002, 293:1364-1369.
89. McKimm-Breschkin J.L. Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance. Treat. Respir. Med. 2005, 4:107-116.
90. Meager A., Visvalingam K., Dilger P., Bryan D., Wadhwa M. Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 2005, 31:109-118.
91. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449:819-826.
92. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
93. Okahira S., Nishikawa F., Nishikawa S., Akazawa T., Seya T., Matsumoto M. Interferon-beta induction through toll-like receptor 3 depends on double-stranded RNA structure. DNA Cell Biol. 2005, 24:614-623.
94. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 2003, 4:161-167.
95. Oxford J.S. Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology. Rev. Med. Virol. 2000, 10:119-133.
96. Parry J. Use of antiviral drug in poultry is blamed for drug resistant strains of avian flu. BMJ 2005, 331:10.
97. Patterson J.B., Thomis D.C., Hans S.L., Samuel C.E. Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. Virology 1995, 210:508-511.
98. Pavlovic J., Haller O., Staeheli P. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 1992, 66:2564-2569.
99. Perkins L.E., Swayne D.E. Pathobiology of A/chicken/Hong Kong/220/97 (H5N1) avian influenza virus in seven gallinaceous species. Vet. Pathol. 2001, 38:149-164.
100. Philbin V.J., Iqbal M., Boyd Y., Goodchild M.J., Beal R.K., Bumstead N., Young J., Smith A.L. Identification and characterization of a functional, alternatively spliced Toll-like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens. Immunology 2005, 114:507-521.
101. Player M.R., Torrence P.F. The 2-,5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol. Ther. 1998, 78:55-113.
102. Qureshi S.T., Lariviere L., Leveque G., Clermont S., Moore K.J., Gros P., Malo D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 1999, 189:615-625.
103. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:588-593.
104. Rudd B.D., Burstein E., Duckett C.S., Li X., Lukacs N.W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol. 2005, 79:3350-3357.
105. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14:778-809.
106. Sanghavi S.K., Reinhart T.A. Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: implications for inflammation and immunodeficiency. J. Immunol. 2005, 175:5314-5323.
107. Scholtissek C. Molecular evolution of influenza viruses. Virus Genes 1995, 11:209-215.
108. Schwarz H., Harlin O., Ohnemus A., Kaspers B., Staeheli P. Synthesis of IFN-beta by virus-infected chicken embryo cells demonstrated with specific antisera and a new bioassay. J. Interferon Cytokine Res. 2004, 24:179-184.
109. Schwarz H., Schneider K., Ohnemus A., Lavric M., Kothlow S., Bauer S., Kaspers B., Staeheli P. Chicken toll-like receptor 3 recognizes its cognate ligand when ectopically expressed in human cells. J. Interferon Cytokine Res. 2007, 27:97-101.
110. Shaw M., Reimer T., Kim Y., Nunez G. NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr. Opin. Immunol. 2008, 20:377-382.
111. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., Kuestner R., Garrigues U., Birks C., Roraback J., Ostrander C., Dong D., Shin J., Presnell S., Fox B., Haldeman B., Cooper E., Taft D., Gilbert T., Grant F.J., Tackett M., Krivan W., McKnight G., Clegg C., Foster D., Klucher K.M. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 2003, 4:63-68.
112. Sick C., Schultz U., Staeheli P. A family of genes coding for two serologically distinct chicken interferons. J. Biol. Chem. 1996, 271:7635-7639.
113. Siren J., Imaizumi T., Sarkar D., Pietila T., Noah D.L., Lin R., Hiscott J., Krug R.M., Fisher P.B., Julkunen I., Matikainen S. Retinoic acid inducible gene-I and MDA-5 are involved in influenza A virus-induced expression of antiviral cytokines. Microbes Infect. 2006, 8:2013-2020.
114. Slingenbergh J.I., Gilbert M., de Balogh K.I., Wint W. Ecological sources of zoonotic diseases. Rev. Sci. Tech. 2004, 23:467-484.
115. Staeheli P., Puehler F., Schneider K., Gobel T.W., Kaspers B. Cytokines of birds conserved functions-a largely different look. J. Interferon Cytokine Res. 2001, 21:993-1010.
116. Subbarao K., Joseph T. Scientific barriers to developing vaccines against avian influenza viruses. Nat. Rev. Immunol. 2007, 7:267-278.
117. Swayne D.E. Occupational and consumer risks from avian influenza viruses. Dev. Biol. (Basel) 2006, 124:85-90.
118. Szretter K.J., Gangappa S., Lu X., Smith C., Shieh W.J., Zaki S., Sambhara S., Tumpey T.M., Katz J.M. Role of host cytokine responses in the pathogenesis of Avian H5N1 influenza viruses in mice. J. Virol. 2007, 81:2736-2744.
119. Takaoka A., Yanai H. Interferon signalling network in innate defence. Cell. Microbiol. 2006, 8:907-922.
120. Takeda K., Akira S. TLR signalling pathways. Semin. Immunol. 2004, 16:3-9.
121. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
122. Takeuchi O., Kawai T., Sanjo H., Copeland N.G., Gilbert D.J., Jenkins N.A., Takeda K., Akira S. TLR6: A novel member of an expanding toll-like receptor family. Gene 1999, 231:59-65.
123. Takeuchi O., Akira S. Innate immunity to virus infection. Immunol. Rev. 2009, 227:75-86.
124. Tatsumi R., Sekiya S., Nakanishi R., Mizutani M., Kojima S., Sokawa Y. Function of ubiquitin-like domain of chicken 2'-5'-oligoadenylate synthetase in conformational stability. J. Interferon Cytokine Res. 2003, 23:667-676.
125. Tanabe M., Kurita-Taniguchi M., Takeuchi K., Takeda M., Ayata M., Ogura H., Matsumoto M., Seya T. Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains. Biochem. Biophys. Res. Commun. 2003, 311:39-48.
126. Theofilopoulos A.N., Baccala R., Beutler B., Kono D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Ann. Rev. Immunol. 2005, 23:307-336.
127. Thompson A.J., Locarnini S.A. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol. Cell Biol. 2007, 85:435-445.
128. Tissari J., Siren J., Meri S., Julkunen I., Matikainen S. IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression. J. Immunol. 2005, 174:4289-4294.
129. Triantafilou K., Triantafilou M., Dedrick R.L. Interactions of bacterial lipopolysaccharide and peptidoglycan with a 70kDa and an 80kDa protein on the cell surface of CD14+ and CD14- cells. Hum. Immunol. 2001, 62:50-63.
130. Van der Poel W.H.M., Lina P.H.C., Kramps J.A. Public health awareness of emerging zoonotic viruses of bats: a European perspective. Vector Borne Zoonotic Dis. 2006, 6:315-324.
131. Wang T., Town T., Alexopoulou L., Anderson J.F., Firkin E., Flavell R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 2004, 10:1366-1373.
132. Webster R.G., Hulse D.J. Microbial adaptation and change: avian influenza. Rev. Sci. Tech. 2004, 23:453-465.
133. Wharton S.A., Belshe R.B., Skehel J.J., Hay A.J. Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine. J. Gen. Virol. 1994, 75(Pt 4):945-948.
134. WHO Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO 2011, Available at:. http://www.who.int/csr/disease/avian_influenza/country/cases_table_2007_01_11/en/index.html.
135. Williams B.R. PKR; a sentinel kinase for cellular stress. Oncogene 1999, 18:6112-6120.
136. Wiwanitkit V. A typical bird flu infection, caused by the H5N1 virus, is a new emerging infectious disease. J. Trauma 2006, 61:768-769.
137. Wong J.P., Nagata L.P., Christopher M.E., Salazar A.M., Dale R.M. Prophylaxis of acute respiratory virus infections using nucleic acid-based drugs. Vaccine 2005, 23:2266-2268.
138. Wright P., Webster R. Orthomyxoviruses. Fields Virology 1996, Lippincott-Raven, Philadelphia, pp. 1397-1427. 3rd ed.
139. Wuest T., Austin B.A., Uematsu S., Thapa M., Akira S., Carr D.J. Intact TRL 9 and type I interferon signalling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10. J. Neuroimmunol. 2006, 179:46-52.
140. Yang K., Puel A., Zhang S., Eidenschenk C., Ku C.L., Casrouge A., Picard C., von Bernuth H., Senechal B., Plancoulaine S., Al-Hajjar S., Al-Ghonaium A., Marodi L., Davidson D., Speert D., Roifman C., Garty B.Z., Ozinsky A., Barrat F.J., Coffman R.L., Miller R.L., Li X., Lebon P., Rodriguez-Gallego C., Chapel H., Geissmann F., Jouanguy E., Casanova J.L. Human TLR-7-,-8, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 2005, 23:465-478.
141. Yang L.S., Yin Z.X., Liao J.X., Huang X.D., Guo C.J., Weng S.P., Chan S.M., Yu X.Q., He J.G. A Toll receptor in shrimp. Mol. Immunol. 2006, 44:1999-2008.
142. Yuen K.Y., Chan P.K., Peiris M., Tsang D.N., Que T.L., Shortridge K.F., Cheung P.T., To W.K., Ho E.T., Sung R., Cheng A.F. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998, 351:467-471.
143. Zamanian-Daryoush M., Mogensen T.H., DiDonato J.A., Williams B.R. NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol. Cell. Biol. 2000, 20:1278-1290.
144. Zarember K.A., Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 2002, 168:554-561.
145. Zhang D., Zhang G., Hayden M.S., Greenblatt M.B., Bussey C., Flavell R.A., Ghosh S. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004, 303:1522-1526.